论文部分内容阅读
1992年7月26～31日在日本横滨市举行了临床药理学与药物治疗学(Clin Pharmacol Ther)第5届世界大会(CPT’92)。本次大会反映了世界临床药理学与药物治疗学的主要研究动向与最新进展。本文从大会126个类目中择其主要进展予以综合评述。 1 临床遗传药理学向分子遗传药理学的发展 遗传药理学研究能揭示人体对药物处置与反应个体差异或种族差异的遗传背景,因而能为临床合理用药提供科学依据。
The 5th World Congress of Clin Pharmacol Ther (CPT’92) was held in Yokohama, Japan from July 26 to July 31, 1992. The conference reflects the world’s clinical pharmacology and pharmacology of the main research trends and the latest developments. This article from the 126 categories of the General Assembly choose its main progress to be comprehensive review. 1 Clinical Genetic Pharmacology to the Development of Molecular Genetic Pharmacology Pharmacological studies to reveal the human body to the drug treatment and response to individual differences or racial differences in the genetic background, which can provide a scientific basis for clinical rational use of drugs.